snip.
← Back to Home ID: 5151
Genes & Diseases Journal @genesndiseases.bsky.social
Jul 4, 03:19 AM

This review examines #CRISPRCas #GenomeEditing in ex vivo and in vivo therapies, emphasizing non‑clinical safety challenges and risk mitigation crucial for translating these technologies into safe clinical applications. @cgtcatapult.bsky.social Read: doi.org/10.1016/j.ge...

💬 Discussion

Genes & Diseases Journal @genesndiseases.bsky.social · Jul 3, 04:48 PM

This review examines #CRISPRCas #GenomeEditing in ex vivo and in vivo therapies, emphasizing non‑clinical safety challenges and risk mitigation crucial for translating these technologies into safe clinical applications. @cgtcatapult.bsky.social Read: doi.org/10.1016/j.ge...